Biological and molecular docking studies on coagulin-H: Human IL-2 novel natural inhibitor

Molecular Immunology

Volumn 43, Issue 11, 2006, Pages 1855-1863

  Mesaik, M Ahmed ^a   Zaheer Ul Haq, ^a   Murad, Shahnaz ^b   Ismail, Zakiah ^b   Abdullah, Noor Rain ^b   Gill, H Kauar ^b   Atta Ur Rahman, ^a   Yousaf, Muhammad ^a   Siddiqui, R Ali ^c,d   Ahmad, Aqeel ^a   Choudhary, M Iqbal ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^c METHODIST RESEARCH INSTITUTE   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

Coagulin H; IL 2R; Immunosuppression; Interleukin 2; Withania coagulans; Withanolide

Indexed keywords

COAGULIN H; INTERLEUKIN 2; PREDNISOLONE; UNCLASSIFIED DRUG; WITHANOLIDE;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANIMALS; BINDING SITES; CATTLE; CELL PROLIFERATION; CYTOTOXICITY, IMMUNOLOGIC; DNA; HUMANS; INTERLEUKIN-2; LYMPHOKINES; MODELS, MOLECULAR; MONOCYTES; PHYTOHEMAGGLUTININS; PREDNISOLONE; PROTEIN BINDING; PROTEIN CONFORMATION; T-LYMPHOCYTES; THROMBOPLASTIN;

WITHANIA COAGULANS;

EID: 33644936754     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2005.10.020     Document Type: Article

References (52)

1. R. Agarwal, S. Diwanay, P. Patki, and B. Patwardhan Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation J. Ethnopharmacol. 67 1999 27 35
2. F. Ahumada, M.A. Trincado, J.A. Arellano, J. Hancke, and G. Wikman Effect of certain adaptogenic plant extract on drug-induced narcosis in female and male mice Phytother. Res. 5 1991 29 31
3. P.A. Akah, A.C. Ezike, S.V. Nwafor, C.O. Okoli, and N.M. Enwerem Evaluation of the anti-asthmatic property of Asystasia gangetica leaf extracts J. Ethnopharmacol. 89 2003 25 36
4. N.A. Ali, W.D. Julich, C. Kusnick, and U. Lindequist Screening of Yemeni medicinal plants for antibacterial and cytotoxic activities J. Ethnopharmacol. 74 2001 173 179
5. Arkin, M.R., Randal, M., DeLano, W.L., Hyde, J., Luong, T.N., Oslob, J.D., Raphael, D.R., Taylor, L., Wang, J., McDowell, R.S., Wells, J.A., Braisted, A.C., 2003. Binding of small molecules to an adaptive protein-protein interface, Note: IUPAC Name of acyl phenyl alanine derivative [methyl (2S)-2-[(2-{3R)-1-[amino(imino)methyl]piperidinyl}acetyl)amino] -3-[4-(2-phenylethynyl)phenyl]propanoate] has been generated using Chem office ver. 6.0. Proc. Natl. Acad. Sci. 100, 1603-1608.
6. Atta-ur-Rahman, M. Yousaf, W. Gul, S. Qureshi, M.I. Choudhary, W. Voelter, A. Hoff, F. Jens, and A. Naz Five new withanolides from Withania coagulans Heterocycles 48 1998 1801 1811
7. R. Bartlett, M. Dimitrijevic, T. Mattar, T. Zielinski, T. Germann, E. Rude, G.H. Thoenes, C.C. Kuchle, H.U. Schorlemmer, E. Bremer, A. Finnegan, and R. Schleyerbach Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection Agents Actions 32 1991 10 21
8. C. Bayly, P. Cieplak, W. Cornell, and P. Kollman A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model J. Phys. Chem. 97 1993 10269 10280
9. J.F. Bazan Unraveling the structure of IL-2 Science 257 1992 410 413
10. P. Burkhard, U. Hommel, M. Sanner, and M.D. Walkinshaw The discovery of steroids and other novel FKBP inhibitors using a molecular docking program J. Mol. Biol. 287 1999 853 858
11. D.A. Cantrell, M.K. Collins, and M.J. Crumpton Autocrine regulation of T-lymphocyte proliferation: differential induction of IL-2 and IL-2 receptor Immunology 65 1988 343 349
12. F.E. Cohen, P.A. Kosen, I.D. Kuntz, L.B. Epstein, T.L. Ciardelli, and K.A. Smith Structure-activity studies of interleukin-2 Science 234 1986 349 352
13. J.E. de Vries, F.A. Vyth-Dreese, C.G. Figdor, H. Spits, J.M. Leemans, and W.S. Bont Induction of phenotypic differentiation, interleukin 2 production, and PHA responsiveness of "immature" human thymocytes by interleukin 1 and phorbol ester J. Immunol. 131 1983 201 206
14. K. Dimas, C. Demetzos, M. Marsellos, R. Sotiriadou, M. Malamas, and D. Kokkinopolos Cytotoxic activity of labdane-type diterpenes against human leukemic cell lines in vitro Planta Med. 64 1998 208 211
15. Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb M.A., Cheeseman J.R., Zakrzewski, V.G., Montgomery, J.A., Stratmann, R.E., Burant, J.C., Dapprich, S., Millam, J.M., Daniels, A.D., Kudin, K.N., Strain, M.C., Farkas, O., Tomasi, J., Barone, V., Cossi, M., Cammi, R., Mennucci, B., Pomelli, C., Adamo, C., Clifford, S., Ochterski, J., Petersson, G.A., Ayala, P.Y., Cui, Q., Morokuma, K., Malick, D.K., Rabuck, A.D., Raghavachari, K., Foresman, J.B., Cioslowski, J., Ortiz, J.V., Stefanov, B.B., Liu, G., Liashenko, A., Piskorz, P., Komaromi, I., Gomperts, R., Martin, R.L., Fox, D.J., Keith, T., Al-Laham, M.A., Peng, C.Y., Nanayakkara, A., Gonzalez, C., Challacombe, M., Gill, P.M.W., Johnson, B.G., Chen, W., Wong, M.W., Andres, J.L., Head-Gordon, M., Replogle, E.S., Pople, J.A., Gaussian Inc., Pittsburgh, P. A., 1998. Gaussian 98, Revision A.4.
16. D.S. Goodsell, and A.J. Olson Automated docking of substrates to proteins by simulated annealing Protein 1990 195 202
17. S.K. Gupta, A. Dua, and B.P. Vohra Withania somnifera (Ashwagandha) attenuates antioxidant defense in aged spinal cord and inhibits copper induced lipid peroxidation and protein oxidative modifications Drug Metabol. Drug Interact. 19 2003 211 222
18. J. Hakimi, D. Mould, T.A. Waldmann, C. Queen, C. Anasetti, and S. Light Development of zenapax (R): a humanized anti-Tac antibody W.J. Harris J.R. Adair Antibody Therapeutics 1997 CRS Publisher 277 300
19. W.R. Heath, J. Allison, M.W. Hoffmann, G. Schonrich, G. Hammerling, B. Miller, and J.F.A.D. Miller Autoimmune diabetes as a consequence of locally produced interleukin-2 Nature 395 1992 547 549
20. K.M. Heaton, and E.A. Grimm Differential inhibition of lymphokine-activated killing, proliferation, and cytokine secretion by humanized antibodies against the low- and intermediate-affinity interleukin-2 receptors. A novel model for activation of human peripheral blood mononuclear cells by interleukin 2 Hum. Immunol. 42 1995 274 280
21. K.M. Heaton, G. Ju, and E.A. Grimm Human interleukin 2 analogues that preferentially bind the intermediate-affinity interleukin 2 receptor lead to reduced secondary cytokine secretion: implications for the use of these interleukin 2 analogues in cancer immunotherapy Cancer Res. 53 1993 2597 2602
22. K.M. Heaton, G. Ju, D.K. Morris, K. Delisio, P. Bailon, and E.A. Grimm Characterization of lymphokine-activated killing by human peripheral blood mononuclear cells stimulated with interleukin 2 (IL-2) analogs specific for the intermediate affinity IL-2 receptor Cell. Immunol. 147 1993 167 179
23. N. Hornung, J. Raskova, J. Raska, and D. Degiannis IL-2 responsiveness of lectin-induced lymphoblasts: soluble IL-2 receptor release and differential in vitro effects of immunosuppressants Int. J. Immunopharmacol. 14 1992 753 760
24. R. Kaempfer Regulation of the human interleukin-2/interleukin-2 receptor system: a role for immunosuppression Proc. Soc. Exp. Biol. Med. 206 1994 176 180
25. S.J. Korsmeyer, W.C. Greene, J. Cossman, S.M. Hsu, J.P. Jensen, L.M. Neckers, S. Marshall, A. Bakhshi, J.M. Depper, W.J. Leonard, E.S. Jaffe, and T.A. Waldmann Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia Proc. Natl. Acad. Sci. U.S.A. 80 1983 4255 4256
26. D. Kovalovsky, D. Refojo, F. Holsboer, and E. Arzt Molecular mechanisms and Th1/Th2 pathways in corticosteroid of cytokine production J. Neuroimmunol. 109 2000 23 29
27. P.V. Leyon, and G. Kuttan Effect of Withania somnifera on B16F-10 melanoma induced metastasis in mice Phytother. Res. 18 2004 118 122
28. C.G. Loftus, L.J. Egan, and W.J. Sandborn Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease Gastroenterol. Clin. North Am. 33 2004 141 169
29. M. Maeda, N. Arima, Y. Daitoku, M. Kashihara, H. Okamato, T. Uchiyama, K. Shirono, M. Matsuoka, T. Hattori, K. Takatsuki, K. Ikuta, A. Shimizu, T. Honjo, and J. Yodoi Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia Blood 70 1987 1407 1411
30. H.M. Manga, D. Brkic, D.E. Marie, and J. Quetin-Leclercq In vivo anti-inflammatory activity of Alchornea cordifolia (Schumach. & Thonn.) Mull. Arg. (Euphorbiaceae) J. Ethnopharmacol. 92 2004 209 214
31. E.L. Mehler, and T. Solmjer Electrostatic effects in proteins: comparison of dielectric and charge models Prot. Eng. 1991 903 910
32. G.M. Morris, D.S. Goodsell, R. Huey, and A.J. Olson Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4 J. Comp.-Aided Mol. Des. 1996 293 304
33. H.R. Mott, B.S. Baines, R.M. Hall, R.M. Cooke, P.C. Driscoll, M.P. Weir, and I.D. Campbell The solution structure of the F42a mutant of human interleukin 2 J. Mol. Biol. 247 1995 979 994
34. N. Mukaida, M. Morita, Y. Ishikawa, N. Rice, S. Okamoto, T. Kasahara, and K. Matsushima Novel mechanism of glucocorticoid-mediated gene repression: NF-KB is a target for glucocorticoid-mediated IL-8 gene repression J. Biol. Chem. 269 1994 13289 13295
35. A.E. Munson Individual antineoplastic drugs A.B. Wingard J. Larner J. Schwartz Human Pharmacology. Molecular to Clinical 1991 Wolfe Publishing Ltd. London 598 600
36. M. Nielsen, J. Gerwien, M. Nielsen, r.C. Geisle, C. Ropke, A. Svejgaard, and N. Odum MHC class II ligation induces CD58 (LFA-3)-mediated adhesion in human T cells Exp. Clin. Immunogenet. 15 1998 61 68
37. F. Paliogianni, S.S. Ahuja, J.P. Balow, J.E. Balow, and D.T. Boumpas Novel mechanism for inhibition of human T cells by glucocorticoids J. Immunol. 151 1993 4081 4089
38. K. Raju, B.A. Rabinovich, L.G. Radvanyi, D. Spaner, and R. Miller A central role for IL-2 in fate determination of mature T cells - I: role in determining the Th1/Th2 profile in primary T cell cultures Int. Immunol. 13 2001 1453 1459
39. J. Sany Prospects in the immunological treatments of rheumatoid arthritis Scand. J. Rheumatol. Suppl. 66 1987 129 136
40. K. Sauve, M. Nachman, C. Spence, P. Bailon, E. Campbell, W.H. Tsien, J.A. Kondas, J. Hakimi, and G. Ju Localization in human interleukin 2 of the binding site to the alpha chain (P55) of the interleukin 2 receptor Proc. Natl. Acad. Sci. U.S.A. 88 1991 4636 4640
41. M. Sayyah, N. Hadidi, and M. Kamalinejad Analgesic and anti-inflammatory activity of lactuca sativa seed extract in rats J. Ethnopharmacol. 92 2004 325 329
42. R. Schwarting, J. Gerdes, and H.J. Stein Expression of interleukin 2 receptor on Hodgkin's and non-Hodgkin's lymphomas and macrophages Clin. Pathol. (Lond.) 38 1985 1196 1197
43. B. Shohat, I. Kirson, and D. Lavie Immunosuppressive activity of two plant steroidal lactones withaferin A and withanolide E Biomedicine 28 1978 18 24
44. S. Somasundaram, J. Sadique, and A. Subramoniam In vitro absorption of [14C] leucine during inflammation and the effect of anti-inflammatory drugs in the jejunum of rats Biochem. Med. 29 1983 259 264
45. J.W. Tilley, L. Chen, D.C. Fry, S.D. Emerson, G.D. Powers, D. Biondi, T. Varnell, R. Trilles, R. Guthrie, F. Mennona, G. Kaplan, R.A. LeMahieu, M. Carson, R.-J. Han, C.-M. Liu, R. Palermo, and G. Ju Identification of a small molecule inhibitor of the IL-2/IL-2R alpha receptor interaction which binds to IL-2 J. Am. Chem. Soc. 119 1997 7589 7590
46. S.A. Tinubu, J. Hakimi, J.A. Kondas, P. Bailon, P.C. Familletti, C. Spence, M.D. Crittenden, G.L. Parenteau, F.M. Dirbas, M. Tsudo, J.D. Bacher, C. Kasten-Sportes, J.L. Martinucci, C.K. Goldman, R.E. Clark, and T.A. Waldmann Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival J. Immunol. 153 1994 4330 4338
47. T. Tsai, C. Hseih, Y. Lin, W. Tsai, and Y.-C. Kuo Enhancement of cell proliferation and cytokines production in human peripheral blood mononuclear cells by extracts from blood enriching Dang-Qui decoction J. Chin. Med. 12 2001 191 202
48. V.N. Tsytsikov, V.V. Yurovsky, S.P. Atamas, W.J. Alms, and B. White Identification and characterization of two alternative splice variants of human interleukin-2 J. Biol. Chem. 271 1996 23055 23060
49. T.A. Waldmann The IL-2/IL-2 receptor system: a target for rational immune intervention Immunol. Today 14 1993 264 270
50. T.A. Waldmann, W.C. Greene, P.S. Sarin, C. Saxinger, D.W. Blayney, W.A. Blattner, C.K. Goldman, K. Bongiovanni, S. Sharrow, J.M. Depper, W. Leonard, T. Uchiyama, and R.C. Gallo Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sezary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor J. Clin. Invest. 73 1984 1711 1718
51. M.P. Weir, M.A. Chaplin, D.M. Wallace, C.W. Dykes, and A.N. Hobden Structure-activity relationships of recombinant human interleukin 2 Biochemistry 27 1988 6883 6892
52. M. Yamamura, X.H. Wang, J.D. Ohmen, K. Uyemura, T.H. Rea, B.R. Bloom, and R.L. Modlin Cytokine patterns of immunologically mediated tissue damage J. Immunol. 149 1992 1470 1475